Abstract
The combined activity of MGBG (metylglyoxal-bis(guanylhydrazone)) with either cisplatin or carboplatin was investigated, towards the human breast cancer cell line MCF-7. While a dose- and time-dependent cytotoxic activity was already observed for MGBG alone, a synergistic and non-reversible effect was verified upon co-administration with these Pt-based drugs. Furthermore, toxicity against non-neoplastic cells was shown to be quite low for these drug cocktails, as opposed to either Pt-agents alone. These results may hopefully allow to use lower dosages of both MGBG and the Ptdrugs, minimising the drugs deleterious side effects while keeping antitumour efficacy, in an anticancer strategy that couples interference with polyamine homeostasis with DNA damage.
Keywords: Anticancer, Breast cancer, Carboplatin, Cisplatin, MGBG, Chemotherapy, MCF-7, Pt-based drugs, homeostasis, myelosuppression, mucositis, antitumour, difluormethylornithine, aromatase inhibitors
Letters in Drug Design & Discovery
Title: MGBG in Combined Anticancer Chemotherapy
Volume: 8 Issue: 10
Author(s): R. F. Goncalves, G. Kriechammer and M. P.M. Marques
Affiliation:
Keywords: Anticancer, Breast cancer, Carboplatin, Cisplatin, MGBG, Chemotherapy, MCF-7, Pt-based drugs, homeostasis, myelosuppression, mucositis, antitumour, difluormethylornithine, aromatase inhibitors
Abstract: The combined activity of MGBG (metylglyoxal-bis(guanylhydrazone)) with either cisplatin or carboplatin was investigated, towards the human breast cancer cell line MCF-7. While a dose- and time-dependent cytotoxic activity was already observed for MGBG alone, a synergistic and non-reversible effect was verified upon co-administration with these Pt-based drugs. Furthermore, toxicity against non-neoplastic cells was shown to be quite low for these drug cocktails, as opposed to either Pt-agents alone. These results may hopefully allow to use lower dosages of both MGBG and the Ptdrugs, minimising the drugs deleterious side effects while keeping antitumour efficacy, in an anticancer strategy that couples interference with polyamine homeostasis with DNA damage.
Export Options
About this article
Cite this article as:
F. Goncalves R., Kriechammer G. and P.M. Marques M., MGBG in Combined Anticancer Chemotherapy, Letters in Drug Design & Discovery 2011; 8 (10) . https://dx.doi.org/10.2174/157018011797655197
DOI https://dx.doi.org/10.2174/157018011797655197 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem
Current Pharmacogenomics and Personalized Medicine Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System
Current Stem Cell Research & Therapy STAT3 as a Central Regulator of Tumor Metastases
Current Molecular Medicine Bioactive Proteins and Peptides from Soybeans
Recent Patents on Food, Nutrition & Agriculture PAF Receptor and Tumor Growth
Current Drug Targets Modifying Radiation Damage
Current Drug Targets Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review
Current Pharmaceutical Design Carbohydrate Antigens: Synthesis Aspects and Immunological Applications in Cancer
Mini-Reviews in Medicinal Chemistry An Integrative Systems Analysis of High-grade Glioma Cell Lines: TLRs, Wnt, BRCA1, Netrins, STXBP1 and MDH1 Provide Putative Molecular Targets for Therapeutic Intervention
Current Pharmacogenomics and Personalized Medicine Hepato and Cardiotoxicity of Chemotherapeutic Treatment Evaluated by Means of Small Animal Imaging
Anti-Cancer Agents in Medicinal Chemistry ERRATUM
Current Drug Targets KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
Current Neuropharmacology Tetracyclines: Drugs with Huge Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Current Strategy for Cisplatin Delivery
Current Cancer Drug Targets Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery Emerging Strategies and Challenges for Controlled Delivery of Taxanes: A Comprehensive Review
Current Drug Metabolism Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Current Pharmaceutical Design ADAM10 as a Target for Anti-Cancer Therapy
Current Pharmaceutical Biotechnology Pharmacophore Searching of Benzofuran Derivatives for Selective CYP19 Aromatase Inhibition
Letters in Drug Design & Discovery